Observational studyPediatric nephrology (Berlin, Germany)2025
Incidence, risk factors, and outcomes of nephrocalcinosis in preterm infants: a prospective cohort study.
Observational study in Pediatric nephrology (Berlin, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical characteristics of nephrocalcinosis in a tertiary children's hospital.Frontiers in pediatrics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundKidneys in preterm infants are exposed to various exogenous factors that may affect their maturation and development. Hence, they are at a higher risk of developing nephrocalcinosis (NC). We aimed to evaluate the incidence, risk factors, and short-term outcomes of NC in preterm neonates admitted to a tertiary-care neonatal unit.
methodsThis prospective observational study included preterm infants born at < 33 weeks gestation. Infants with congenital anomalies of the kidney and urinary tract (CAKUT) or major malformations were excluded. Ultrasound scans were performed at 3-6 weeks of postnatal age to screen for NC using a modified grading system. Clinical data, including demographics, respiratory support, medication exposure, nutrition, and biochemical markers, were collected. Infants with NC were followed up at 3 and 6 months of corrected age to assess the resolution of NC and kidney function.
resultsAmong the 152 enrolled neonates, 23 (15.1%) had NC. Respiratory distress syndrome (RDS) (adjusted odds ratio [aOR] 3.6; 95% CI: 1.1-12.3; p = 0.04) and total parenteral nutrition (TPN) (aOR-4.5; 95% CI: 1.2-16.8; p = 0.03) were independently associated with NC. At 3 months, 17 of the 23 infants were re-evaluated, and NC resolved in 13 (76.5%). By 6-8 months, all but one infant showed resolution. All the infants had normal kidney function at the last follow-up.
conclusionNephrocalcinosis occurred in 15% of preterm neonates and was significantly associated with RDS and TPN use. Most cases resolved spontaneously without adverse outcomes. These findings support targeted NC screening in high-risk neonates.
Indexed as
Identifiers
40660023What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.